Question 1

What is the share price of Global Health Limited today?

Accepted Answer

Global Health Limited (MEDANTA) is trading at ₹1,270.3. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is MEDANTA’s P/E ratio versus the sector?

Accepted Answer

MEDANTA trades at a P/E of 81.0. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is MEDANTA’s dividend yield?

Accepted Answer

MEDANTA has a dividend yield of 0.03%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is MEDANTA’s 52-week high and low?

Accepted Answer

MEDANTA has traded between ₹956 and ₹1,544 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of Global Health Limited?

Accepted Answer

Global Health Limited has a market capitalisation of ₹40,226 crore.

Question 6

What is MEDANTA’s return on equity?

Accepted Answer

MEDANTA reports a return on equity of 13.2%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Medical Care Facilities.

Question 7

Who are MEDANTA’s competitors?

Accepted Answer

The Peers block on this page lists other Medical Care Facilities companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is MEDANTA’s promoter holding?

Accepted Answer

Promoters hold 33.00% of MEDANTA. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include MEDANTA?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight MEDANTA carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is Global Health Limited a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from MEDANTA’s own numbers. The judgement is yours.

MEDANTA

MEDANTA

Value & Investment Index

VII Detail

Multiples vs Peers

Quality Scores

Versus Its Own History

Scenario analysis

MEDANTA valuation summary

P/E	81.0
ROE	13.2%
ROCE	16.4%
Dividend yield	0.03%